Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
Clinical trial NCT02312037 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02312037
- Sponsor
- Pfizer
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.